UniSa - IRIS Institutional Research Information System

ESPOSITO, Carla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.428
AS - Asia 4.342
EU - Europa 2.047
SA - Sud America 296
AF - Africa 30
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.149
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.330
HK - Hong Kong 2.163
SG - Singapore 904
CN - Cina 734
IT - Italia 512
UA - Ucraina 493
VN - Vietnam 273
DE - Germania 263
BR - Brasile 259
RU - Federazione Russa 221
FI - Finlandia 156
IE - Irlanda 139
TR - Turchia 81
SE - Svezia 76
GB - Regno Unito 52
FR - Francia 48
MX - Messico 47
KR - Corea 45
CA - Canada 40
IN - India 40
JP - Giappone 20
PL - Polonia 19
AR - Argentina 16
BD - Bangladesh 16
ZA - Sudafrica 15
ES - Italia 14
IQ - Iraq 14
CZ - Repubblica Ceca 13
IL - Israele 7
PK - Pakistan 7
AT - Austria 6
CL - Cile 5
ID - Indonesia 5
JO - Giordania 5
LT - Lituania 5
PH - Filippine 5
RS - Serbia 5
VE - Venezuela 5
CO - Colombia 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
EC - Ecuador 3
NL - Olanda 3
RO - Romania 3
UZ - Uzbekistan 3
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
KE - Kenya 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
Totale 13.149
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.161
Ann Arbor 1.338
Wilmington 691
Chandler 619
Jacksonville 596
Dallas 511
Singapore 428
Princeton 393
Ashburn 266
Houston 265
Dong Ket 210
Woodbridge 209
Beijing 145
Munich 139
Dublin 136
Boardman 111
Nanjing 110
Dearborn 107
Andover 97
Pellezzano 76
Salerno 65
Izmir 62
Los Angeles 49
Mestre 49
Moscow 49
Fairfield 41
Helsinki 41
Redwood City 37
Nanchang 35
The Dalles 35
Hebei 33
Shenyang 33
New York 30
São Paulo 30
Changsha 27
Ho Chi Minh City 26
Tianjin 21
Jiaxing 20
Tokyo 20
Pune 19
Warsaw 19
Montreal 18
Napoli 16
Sant'agata De' Goti 16
Washington 15
Brooklyn 14
Cuauhtémoc 14
Orem 14
Santa Clara 14
Agropoli 13
Brno 12
London 12
Norwalk 12
Phoenix 12
Stockholm 12
Turku 12
Belo Horizonte 11
Cava 11
Düsseldorf 11
Johannesburg 11
Ottawa 11
San Diego 11
Seattle 11
Guangzhou 10
Chennai 9
Chicago 9
Istanbul 9
Lessolo 9
Poplar 9
Boston 8
Hanoi 8
Manchester 8
Naples 8
Potenza 8
Rio de Janeiro 8
Spinea 8
Atlanta 7
Bari 7
Bologna 7
Caserta 7
Council Bluffs 7
Jinan 7
Ankara 6
Denver 6
Kunming 6
Marsico Nuovo 6
Mexico City 6
Shanghai 6
Amman 5
Belgrade 5
Charlotte 5
Curitiba 5
Hefei 5
Portici 5
Querétaro 5
San Francisco 5
Springfield 5
Vienna 5
Brasília 4
Cambridge 4
Totale 9.879
Salva come PNG Salva come JPEG
Nome #
Searching for the protein targets of 4-nonylphenol using a computational approach 700
Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells 631
A preliminary study on nonylphenol toxicity in human intestinal epithelial cells 551
The surfactant 4-nonylphenol is cytotoxic for cells of the human gastrointestinal tract. 316
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases. 263
Searching for the protein targets of 4-nonylphenol using a computational approach 244
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. 227
Analysis of transglutaminase protein substrates by functional proteomics. 211
4-Nonylphenol reduces cell viability and induces apoptosis and ER-stress in a human epithelial intestinal cell line 183
Anti-tissue transglutaminase antibodies activate intracellular tissue transglutaminase by modulating cytosolic Ca(2+) homeostasis 173
An acetic acid-based extraction method to obtain high quality collagen from archeological bone remains 173
Celiac anti‑type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects 169
Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease 169
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells 167
Antibodies against type 2 transglutaminase modulate actin rearrangements and cell cycle in several cell lines 155
Application of a computational approach to identify protein targets for 4-nonylphenol 155
The toxic alpha-gliadin peptide 31-43 enters cells without a surface membrane receptor 152
Celiac autoantibodies to tissue transglutaminase modulate alpha-gliadin peptide uptake by epithelial cells 144
Enzymatic Strategies to Detoxify Gluten:Implications for Celiac Disease 141
Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics 141
THE A-GLIADIN PEPTIDE 31-43 INDUCES NF-kB ACTIVATION AND MODULATE TYPE 2 TRANSGLUTAMINASE ACTIVITY IN AN INTESTINAL EPITHELIAL CELL LINE 140
Autoantibodies to tissue transglutaminase can induce ER (endoplasmic reticulum) stress response in Caco-2 cells 138
Chronic Exposure to Cadmium Disrupts the Adrenal Gland Activity of the Newt Triturus carnifex (Amphibia, Urodela) 138
Interaction of 'toxic' and 'immunogenic' A-gliadin peptides with a membrane-mimetic environment 137
Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca(2+) Mobilization in Caco-2 Cells. 137
Anti-Tissue Transglutaminase Antibodies from Coeliac Patients Inhibit Transglutaminase Activity both in Vitro and in Situ 136
Identification of differential phosphorylated proteins in Caco-2 cells treated with anti-tissue transglutaminase antibodies 135
A-gliadin peptide 31-43 induces NF-κB and tissue transglutaminase activation in an intestinal epithelial cell line 134
Synthesis of peptidocalix[4]arene diversomers as transglutaminase inhibitors by protein surface recognition 134
ANTI-TISSUE TRANSGLUTAMINASE ANTIBODIES ACTIVATE CYTOSOLIC TISSUE TRANSGLUTAMINASE BY MOBILIZING CALCIUM IONS FROM INTRACELLULAR STORES 133
Tissue transglutaminase in celiac disease: role of autoantibodies. 131
Biochemical characterization of recombinant rat prostate transglutaminase expressed into MDCK cells 127
Anti-tissue transglutaminase antibodies have biological effects on cultured intestinal biopsies from celiac patients 122
A-GLIADIN PEPTIDES INDUCE TISSUE TRANSGLUTAMINASE ACTIVATION THROUGH CA2+ MOBILIZATION IN CACO-2 CELLS 119
Caratterizzazione della transglutaminasi da prostata di ratto espressa in cellule MDCK 118
Serum IgA and IgG and intestinal monoclonal anti-tissue transglutaminase antibodies from coeliac patients inhibit the catalytic activity both in vitro and in situ. 117
Subcellular distribution of type 2 transglutaminase is constitutively different in skin derived-fibroblasts from celiac disease patients and from healthy controls 115
Internalization of alpha gliadin peptide 31-43 by Caco-2 cells does not require a surface receptor. 114
New therapeutic strategies for coeliac disease: tissue transglutaminase as a target 113
Histological changes, apoptosis and metallothionein levels in Triturus carnifex (Amphibia, Urodela) exposed to environmental cadmium concentrations 112
Mammalian Transglutaminases. Identification of substrates as a key to physiological function and physiopathological relevance. 111
RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies. 111
N-terminus end of rat prostate transglutaminase is responsible for its catalytic activity and GTP binding 111
Expression and enzymatic activity of small intestinal tissue transglutaminase in coeliac disease 110
Constitutive differential features of type 2 transglutaminase in cells derived from celiac patients and from healthy subjects 108
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types 106
Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line: implications for coeliac disease. 104
Type 2 transglutaminase contributes to define a cellular phenotype typical of celiac cells. 104
Transglutaminase 2 in celiac diasease: Minireview article 103
Celiac anti-tissue transglutaminase autoantibodies interfere with the ability of alpha-gliadin peptide 31-43 to drive intestinal epithelial cells into S-phase. 103
Celiac anti-tissue transglutaminase antibodies derange alpha gliadin peptide 31-43 uptake by epithelial cells. 103
Tissue Transglutaminase and Coeliac Disease. 100
GTPase and transglutaminase are associated in the secretion of rat anterior prostate. 99
null 98
Studi di specificità di isoforme dell'enzima transglutaminasi per modificare proteine del latte 98
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate deydrogenase and polyglutamine repeat. 98
Transglutaminase surface recognition by peptidocalix[4]arene diversomers. 97
Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting. 97
The monoclonal anti-tissue transglutaminase antibody CUB 7402 reduces the alpha-gliadin peptides uptake by Caco-2 cells 97
Expression and Enzymatic Activity of Small Intestinal Tissue Transglutaminase in Coeliac Disease 96
Tissue transglutaminase is implicated in the antiproliferative and proapoptotic effect induced by the histone deacetylase inhibitor 95
Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types 93
Interplay between type 2 transglutaminase (Tg2), gliadin peptide 31-43 and anti-tg2 antibodies in celiac disease 91
Non celiac patients’ anti-tissue transglutaminase antibodies: immunological and functional characterization. 90
Identification of acyl-acceptor and acyl-donor substrates for transglutaminase in CaCo-2 intestinal cell line: implications for coeliac disease 89
The Pituitary-adrenal gland Activity of Triturus carnifex (Amphibia, Urodela) exposed to Environmental Cadmium Concentrations 89
Riconoscimento di superficie delle transglutamminasi mediante diversomeri peptidocalix[4]arenici 87
Serum immunoglobulin A and G and monoclonal antibodies anti tissue-transglutaminase from coeliac patients inhibit the catalytic activity both in vitro and in situ. 87
Studio del riconoscimento tra transglutaminasi di tipo 2 e auto-anticorpi anti-transglutaminasi caratteristici della malattia celiaca 86
Effects of Methyl Bromide on activity of blood coagulation enzymes 86
Influenza delle modifiche post-traduzionali sulle proprietà biologiche della TGasi presente nel secreto della ghiandola coagulatoria 84
Implication of cell-surface transglutaminase in gliadin peptides uptake by Caco-2 cells 84
Transglutaminase surface recognition by peptidocalix[4]arene diversomers 83
Transglutaminase-mediated amine incorporation into substance P protects the peptide against proteolysis in vitro. 82
Transglutaminase-synthesized spermine derivative of substance P recognizes rat portal vein neurokinin-3 receptors. 80
Interaction of “toxic” and “immunogenic” A-gliadin peptides with a membrane-like environment in vitro. 80
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. 78
Transglutaminase-synthesized analogs of substance P is a selective tool for neurokinin-2 receptors. 77
Rat coagulating gland secretion contains a kinesin heavy chain-like protein acting as type IV transglutaminase substrate 77
Studies on transglutaminase type IV in relation to proteins occuring in rat coagulating gland secretion 77
Characterisation of rat coagulating gland transglutaminase expressed in heterologous cell systems 77
Ubiquitination of tissue transglutaminase is modulated by interferon alpha in human lung cancer cells 76
Role of type 2 transglutaminase autoantibodies in phatogenesis of celiac disease 76
Tissue transglutaminase autoantibodies regulate actin rearrangements and cell cycle in several cell types. 75
Do tissue transglutaminase antibodies contribute to the intestinal lesion in celiac disease? 75
Identification of tissue transglutaminase-reactive lysine residues in glyceraldheide-3-phosphate dehydrogenase 74
Transglutaminase-mediated polyamination of vasoactive intestinal peptide (VIP) Gln16 residue modulates the VIP/PACAP receptor activity. 74
The mechanism of cytotoxicity of 4-nonylphenol in a human hepatic cell line involves ER-stress, apoptosis, and mitochondrial dysfunction 73
Implication of tissue transglutaminase and desmoplakin in cell adhesion mechanism in human epidermis 72
Enzymatic synthesis of vasoactive intestinal peptide analogs by transglutaminase. 72
Overlapping between fluorescence modifications and activation of prostate transglutaminase induced by sodium dodecylsulphate. 72
null 71
Desmoplakin acts as transglutaminase substrate in vitro. 70
Espressione e attività enzimatica della transglutaminasi tissutale nella mucosa intestinale di pazienti celiaci 70
Protein SV-IV promotes nitric oxide production not associated with apoptosis in murine macrophages. 69
IgA e IgG sieriche e anticorpi monoclonali intestinali anti-transglutaminasi tissutale ottenuti da pazienti celiaci inibiscono l'attività catalitica sia in vitro che in situ 67
null 67
Expression and enzymatic activity of transglutaminase in the normal and coeliac small intestinal mucosa 66
Coeliac disease and extraintestinal autoimmunity. 64
Structural characterisation of transglutaminase-catalysed protein aggregates correlated to neurodegenerative disorders. 64
Totale 12.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021640 0 0 0 0 0 37 112 9 132 13 115 222
2021/2022769 0 0 4 2 40 13 1 25 114 87 121 362
2022/20231.343 134 103 31 176 186 260 0 166 196 0 64 27
2023/2024465 48 68 33 21 38 81 23 31 0 26 19 77
2024/20251.308 62 27 54 88 58 147 268 146 183 33 112 130
2025/20264.169 540 980 1.501 330 592 226 0 0 0 0 0 0
Totale 13.361